Common use of Exceptions to Non-Disclosure Clause in Contracts

Exceptions to Non-Disclosure. Notwithstanding Sections 16.2 and 16.3, if the Institution or the Principal Investigator are legally required to disclose Confidential Information or results of the Study, the Institution or the Principal Investigator, as applicable and to the extent permitted by law, shall use reasonable efforts to promptly notify SPONSOR in writing prior to making the required disclosure. If such disclosure is required pursuant to a lawful subpoena or judicial or government request or order, the Institution and the Principal Investigator shall permit SPONSOR to defend against any such order of disclosure and the Institution shall assist, at SPONSOR’s expense, in such defense to the extent permitted by Applicable Laws. If the Institution or the Principal Investigator is thereafter or otherwise required to disclose any Confidential Information, the Institution or the Principal Investigator, as applicable, shall use reasonable efforts under the circumstances to craft such disclosure as reasonably requested by SPONSOR so that such disclosure shall contain only such Confidential Information as is required by Applicable Laws. Nothing contained herein shall prohibit the Institution or the Principal Investigator from immediately disclosing information relating to the Study to those individuals who have a need to know to mitigate a serious health hazard; provided, however, that the Institution or the Principal Investigator, as applicable, shall notify SPONSOR prior to making such a disclosure, to the extent practicable, and promptly after it has made such a disclosure.

Exceptions to Non-Disclosure. Notwithstanding Sections 16.2 15.2 and 16.315.3, if the Institution or the Principal Investigator are legally required to disclose Confidential Information or results of the Study, the Institution or the Principal Investigator, as applicable and to the extent permitted by lawapplicable, shall use reasonable efforts to promptly notify SPONSOR in writing writing, but no less than five (5) business days, prior to making the required disclosure. If such disclosure is required pursuant to a lawful subpoena or judicial or government request or order, the Institution and the Principal Investigator shall permit SPONSOR to defend against any such order of disclosure and the Institution shall assist, at SPONSOR’s expense, in such defense to the extent permitted by Applicable Lawsapplicable laws. If the Institution or the Principal Investigator is thereafter or otherwise required to disclose any Confidential Information, the Institution or the Principal Investigator, as applicable, shall use reasonable efforts under the circumstances to craft such disclosure as reasonably requested by SPONSOR so that such disclosure shall contain only such Confidential Information as is required by Applicable Lawsapplicable laws. Nothing contained herein shall prohibit the Institution or the Principal Investigator from immediately disclosing information relating to results of the Study to those individuals who have a need the extent necessary to know to prevent or mitigate a serious health hazard; provided, however, that the Institution or the Principal Investigator, as applicable, shall notify SPONSOR prior to making such a disclosure, to the extent practicable, disclosure and promptly after it has made such a disclosure.

Exceptions to Non-Disclosure. Notwithstanding Sections 16.2 and 16.3, if the Institution or the Principal Investigator are legally required to disclose Confidential Information or results of the StudyTrial, the Institution or the Principal Investigator, as applicable and to the extent permitted by law, shall use reasonable efforts to promptly notify SPONSOR in writing prior to making the required disclosure. If such disclosure is required pursuant to a lawful subpoena or judicial or government request or order, the Institution and the Principal Investigator shall permit SPONSOR to defend against any such order of disclosure and the Institution shall assist, at SPONSOR’s expense, in such defense to the extent permitted by Applicable Laws. If the Institution or the Principal Investigator is thereafter or otherwise required to disclose any Confidential Information, the Institution or the Principal Investigator, as applicable, shall use reasonable efforts under the circumstances to craft such disclosure as reasonably requested by SPONSOR so that such disclosure shall contain only such Confidential Information as is required by Applicable Laws. Nothing contained herein shall prohibit the Institution or the Principal Investigator from immediately disclosing information relating to the Study Trial to those individuals who have a need to know to mitigate a serious health hazard; provided, however, that the Institution or the Principal Investigator, as applicable, shall notify SPONSOR prior to making such a disclosure, to the extent practicable, and promptly after it has made such a disclosure.

Exceptions to Non-Disclosure. Notwithstanding Sections 16.2 15.2 and 16.315.3, if the Institution or the Principal Investigator are legally required to disclose Confidential Information or results of the Study, the Institution or the Principal Investigator, as applicable and to the extent permitted by lawapplicable, shall use reasonable efforts to promptly notify SPONSOR AstraZeneca in writing writing, but no less than three (3) business days, prior to making the required disclosure. If such disclosure is required pursuant to a lawful subpoena or judicial or government request or order, the Institution and the Principal Investigator shall permit SPONSOR AstraZeneca to defend against any such order of disclosure and the Institution shall assist, at SPONSORAstraZeneca’s expense, in such defense to the extent permitted by Applicable Laws. If the Institution or the Principal Investigator is thereafter or otherwise required to disclose any Confidential Information, the Institution or the Principal Investigator, as applicable, shall use reasonable efforts under the circumstances to craft such disclosure as reasonably requested by SPONSOR AstraZeneca so that such disclosure shall contain only such Confidential Information as is required by Applicable Laws. Nothing contained herein shall prohibit the Institution or the Principal Investigator from immediately disclosing information relating to results of the Study to those individuals who have a need the extent necessary to know to prevent or mitigate a serious health hazard; provided, however, that the Institution or the Principal Investigator, as applicable, shall notify SPONSOR AstraZeneca prior to making such a disclosure, to the extent practicable, disclosure and promptly after it has made such a disclosure.